Hannover Rück (HNR1) CMD 2025 summary
Event summary combining transcript, slides, and related documents.
CMD 2025 summary
9 Oct, 2025Strategic direction and future plans
No major changes in strategy or new financial guidance were announced; the current strategy cycle continues through 2026, with updates expected in November 2025.
On track to exceed targets for the 2024–2026 strategy cycle, with 1H 2025 ROE at 23% and EBIT growth at 6.3% over prior periods.
Focus remains on organic growth, leveraging strong client relationships and a lean, pure-play reinsurance model.
Ongoing investment in automation and AI, streamlined IT, and a lean operating model drive efficiency, scalability, and cost advantages.
M&A is not a priority; organic growth is expected to continue, especially in underweight markets and business lines.
Financial guidance and capital management
The payout ratio is set to increase to around 55% of IFRS net income, transforming the special dividend into a regular component for a more predictable run rate.
Solvency II ratio remains robust at 261% in 1H 2025, well above the 200% target, but is expected to trend lower due to growth assumptions while maintaining a buffer.
Strong capital position and improved German GAAP balance sheet provide flexibility for growth and attractive dividends.
Commitment to sustainable value creation and structurally higher capital returns to shareholders.
Reserve resiliency in P&C and life and health remains high, supporting earnings stability and offering levers for future profit management.
Business developments and operational highlights
Lean operating model delivers a cost ratio of 3.2% and high revenue per employee, outperforming peers.
P&C: Continued appetite for growth in NatCat, with improved diversification and capital efficiency; strong client demand and a low-cost ratio support profitability even in softer markets.
Life & Health: Reliable, increasing run rate with prudent assumption setting; CSM growth underpins future earnings, and new business opportunities are targeted in underweight regions.
Investments: Attractive, stable returns with low volatility; book yield is expected to rise further as higher market yields are locked in, and hidden losses are being actively managed.
Structured and ILS business lines are expected to continue growing, with structured business showing mid-20s growth rates and resilience through cycles.
Latest events from Hannover Rück
- Net income up 13.4%, dividend rises nearly 40%, and 2026 guidance signals continued growth.HNR1
Q4 202512 Mar 2026 - Net income up 20.9% to €1.16bn, with strong P&C growth and robust capital position.HNR1
Q2 20241 Feb 2026 - Raised 2025 net income guidance to ~€2.6bn, with 21.2% ROE and strong capitalisation.HNR1
Company presentation26 Jan 2026 - Net income rose 30.4% to €1.82bn, raising 2024 guidance to €2.3bn on strong P&C results.HNR1
Q3 202415 Jan 2026 - 2025 guidance reaffirmed despite LA wildfire losses, with strong premium growth and disciplined renewals.HNR1
Status Update8 Jan 2026 - Net income up 27.6% to EUR 2,329m, dividend up 25%, and solvency ratio at 261%.HNR1
Q4 20242 Dec 2025 - Net income up 13.2% to EUR 1.3 billion, with strong growth and robust capital position.HNR1
Q2 202523 Nov 2025 - Net income dropped 13.9% on wildfire losses, but guidance and capital strength remain solid.HNR1
Q1 202518 Nov 2025 - 2025 net income guidance raised to EUR 2.6bn on strong results, prudent reserving, and higher investment income.HNR1
Q3 202510 Nov 2025